Michael Craig Email

Head Publications . Rhythm Pharmaceuticals

Boston, MA

Location

m*****@rhythmtx.com

Primary Email

Current Roles

Employees:
373
Revenue:
$5.9M
About
Rhythm is a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic disorders of obesity. Rhythm's lead product candidate is setmelanotide, a first-in-class melanocortin-4 receptor (MC4R) agonist. Rhythm supports The Genetic Obesity Project (GeneticObesity.com) and the GO-ID Genotyping Study (GeneticObesityID.com).
Rhythm Pharmaceuticals Address
222 Berkeley Street
Boston, MA
United States
Rhythm Pharmaceuticals Email

Past Companies

Rhythm Pharmaceuticals Inc.Head of Publications
Sage TherapeuticsDirector, Medical Publications
Sage TherapeuticsAssociate Director Medical Publications & Communications